Is a purified protein derivative skin test and subsequent antituberculous chemoprophylaxis really necessary in systemic rheumatic disease patients receiving corticosteroids?

Clinical Rheumatology

Volumn 17, Issue 3, 1998, Pages 181-185

  Andonopoulos, A P ^a,b   Safridi, C ^a   Karokis, D ^a   Bounas, A ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

Author keywords

Antituberculous chemoprophylaxis; Corticosteroid treatment; Purified protein derivative skin test; Systemic rheumatic diseases

Indexed keywords

CORTICOSTEROID; ISONIAZID; METHYLPREDNISOLONE; STEROID; TUBERCULOSTATIC AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CORTICOSTEROID THERAPY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; SKIN TEST; THORAX RADIOGRAPHY; TREATMENT INDICATION; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CONFIDENCE INTERVALS; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISONIAZID; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RHEUMATIC DISEASES; RISK ASSESSMENT; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0031870595     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01451043     Document Type: Article

References (10)

1. Daniel TM. Tuberculosis. In: Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci AS, Root RK, editors. Harrison's principles of internal medicine, 12th edn. New York: McGraw-Hill, 1993:637-45.
2. Shan SA, Lakshminaraya S. Tuberculosis after corticosteroid therapy. Br J Dis Chest 1976;70:195-205.
3. Des Prez RM, Heim GR. Mycobacterium tuberculosis. In: Mandell CL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases, 3rd edn. New York: Churchill Livingstone, 1990:1877-1906.
4. Kopanoff DE, Snider DE, Garas GJ. Isoniazid related hepatitis. A U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis 1978;117:991-1001.
5. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Bouros D, Demoiliopoulos I, Moschos M, Panagou P, Demoiliopoulos D, Konstantopoulos S, Siafakas N. Tuberculin sensitivity trends in Hellenic army recruits during the period 1981-91. Tubercle Lung Dis 1995;76:126-9.
8. Bouros D, Zeros G, Panaretos C, Vassilatos C, Siafakas N. Palpation versus pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest 1991;99:416-9.
9. Bouros D, Maltezakis G, Tzanakis N, Tzortzaki E, Siafakas N. The role of inexperience in measuring tuberculin (Mantoux test) by the pen or palpation technique. Respir Med 1992;86:219-33.
10. Malone D, Wahl S, Tsokos M, Cattel H, Decker JL, Wilder RL. Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest 1984;1173-85.